Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001756744 | SCV001987691 | uncertain significance | not provided | 2019-05-31 | criteria provided, single submitter | clinical testing | Reported in two patients with leukoencephalopathy; however further clinical and familial segregation information were not provided (Ungaro et al., 2009); Reported in a patient with history of a lacunar stroke and hypertension; however, information about parental testing was not provided and functional characterization of the variant was not performed (Kilarski et al., 2015); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; This variant is associated with the following publications: (PMID: 26305465, 19006080) |
Athena Diagnostics | RCV001756744 | SCV004229494 | uncertain significance | not provided | 2023-07-05 | criteria provided, single submitter | clinical testing | Available data are insufficient to determine the clinical significance of the variant at this time. The frequency of this variant in the general population is higher than would generally be expected for pathogenic variants in this gene (http://gnomad.broadinstitute.org). Computational tools disagree on the variant's effect on normal protein function. Greater than 90% of NOTCH3 pathogenic variants associated with CADASIL involve the gain or loss of a cysteine residue within the epidermal growth factor (EGF)-like repeat domain (PMID: 32457593, 20301673). |